These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
218 related articles for article (PubMed ID: 32545874)
41. Genome-wide CRISPR/Cas9 knockout screening uncovers a novel inflammatory pathway critical for resistance to arginine-deprivation therapy. Chu CY; Lee YC; Hsieh CH; Yeh CT; Chao TY; Chen PH; Lin IH; Hsieh TH; Shih JW; Cheng CH; Chang CC; Lin PS; Huang YL; Chen TM; Yen Y; Ann DK; Kung HJ Theranostics; 2021; 11(8):3624-3641. PubMed ID: 33664852 [TBL] [Abstract][Full Text] [Related]
42. ASS1 as a novel tumor suppressor gene in myxofibrosarcomas: aberrant loss via epigenetic DNA methylation confers aggressive phenotypes, negative prognostic impact, and therapeutic relevance. Huang HY; Wu WR; Wang YH; Wang JW; Fang FM; Tsai JW; Li SH; Hung HC; Yu SC; Lan J; Shiue YL; Hsing CH; Chen LT; Li CF Clin Cancer Res; 2013 Jun; 19(11):2861-72. PubMed ID: 23549872 [TBL] [Abstract][Full Text] [Related]
43. Rational design, engineer, and characterization of a novel pegylated single isomer human arginase for arginine depriving anti-cancer treatment. Yu KM; Pang TP; Cutler M; Tian M; Huang L; Lau JY; Chung SF; Lo TW; Leung TY Life Sci; 2021 Jan; 264():118674. PubMed ID: 33129876 [TBL] [Abstract][Full Text] [Related]
44. Discovery and Targeting of a Noncanonical Mechanism of Sarcoma Resistance to ADI-PEG20 Mediated by the Microenvironment. Rogers LC; Kremer JC; Brashears CB; Lin Z; Hu Z; Bastos ACS; Baker A; Fettig N; Zhou D; Shoghi KI; Dehner CA; Chrisinger JSA; Bomalaski JS; Garcia BA; Oyama T; White EP; Van Tine BA Clin Cancer Res; 2023 Aug; 29(16):3189-3202. PubMed ID: 37339179 [TBL] [Abstract][Full Text] [Related]
45. Decreased argininosuccinate synthetase expression in Thai patients with cholangiocarcinoma and the effects of ADI-PEG20 treatment in CCA cell lines. Roeksomtawin S; Navasumrit P; Waraprasit S; Parnlob V; Sricharunrat T; Bhudhisawasdi V; Savaraj N; Ruchirawat M Oncol Lett; 2018 Aug; 16(2):1529-1538. PubMed ID: 30008833 [TBL] [Abstract][Full Text] [Related]
46. Bench-to-Bedside Studies of Arginine Deprivation in Cancer. Field GC; Pavlyk I; Szlosarek PW Molecules; 2023 Feb; 28(5):. PubMed ID: 36903394 [TBL] [Abstract][Full Text] [Related]
47. Arginine deprivation by arginine deiminase of Streptococcus pyogenes controls primary glioblastoma growth in vitro and in vivo. Fiedler T; Strauss M; Hering S; Redanz U; William D; Rosche Y; Classen CF; Kreikemeyer B; Linnebacher M; Maletzki C Cancer Biol Ther; 2015; 16(7):1047-55. PubMed ID: 25774632 [TBL] [Abstract][Full Text] [Related]